aims relationship polymorphisms positions NUMBER NUMBER acute systemic effects inhaled salbutamol unclear elected evaluate influence common homozygous haplotypes acute systemic effects following inhaled salbutamol asthmatic subjects methods initial database search NUMBER asthmatic subjects identified commonest homozygous haplotypes positions NUMBER NUMBER NUMBER NUMBER washout period agonists withdrawn NUMBER caucasian subjects n NUMBER n NUMBER given single dose inhaled salbutamol NUMBER microg followed serial blood sampling serum potassium measurements diastolic blood pressure heart rate intervals NUMBER min results groups matched age sex fev1 inhaled corticosteroid dose baseline values serum potassium diastolic blood pressure heart rate significantly different comparing vs mean sem maximum serum potassium change baseline NUMBER min significantly greater p NUMBER NUMBER NUMBER mmol vs NUMBER NUMBER mmol NUMBER ci difference mmol maximum diastolic blood pressure change baseline NUMBER min significantly greater p NUMBER NUMBER NUMBER mmhg vs NUMBER NUMBER mmhg NUMBER ci difference NUMBER mmhg significant difference comparing maximum heart rate change baseline NUMBER NUMBER beats vs NUMBER NUMBER beats conclusions caucasian asthmatic subjects haplotype exhibited greater systemic response inhaled salbutamol compared haplotype attenuated response haplotype keeping increased susceptibility prior endogenous catecholamines beta2 adrenoceptor beta2 adrenoceptor beta2 adrenoceptor beta2 adrenoceptor arg16 gln27 gly16 glu27 NUMBER week beta2 adrenoceptor arg16 gln27 gly16 glu27 NUMBER min arg16 gln27 gly16 glu27 arg16 gln27 l NUMBER gly16 glu27 l NUMBER NUMBER NUMBER l NUMBER arg16 gln27 gly16 glu27 NUMBER arg16 gln27 min NUMBER gly16 glu27 min NUMBER arg16 gln27 gly16 glu27 beta2 adrenoceptor gly16 glu27 regulation